Project
Exogenus Therapeutics
Descriptor
Exogenus Therapeutics develops innovative exosome-based therapies targeting inflammatory and autoimmune diseases, including severe lung inflammation caused by COVID-19.
Tool
Growth Programme
Product
Blue Bio Value
Learn more
SDG
3: Good Health and Well-being
Impact factsheet